Garlic proves potent in reducing blood sugar and cholesterol, study reveals

FHS
June 3, 2024
2:39 am

Study confirms garlic’s significant benefits in lowering blood glucose and lipid levels, offering a natural remedy for metabolic disorders.

Aclaris makes a deal, aims to raise $80M; Emmecell’s Ph1 update in corneal edema

Plus, news about Keymed Biosciences, Ouro Medicines, Recode, Intellia, Quell, VBI Vaccines and Zai Lab: Aclaris adds two anti-TSLP programs, seeks $80M: The new pipeline

November 19, 2024

PDS-01ADC by PDS Biotechnology for Colorectal Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 4, 2024

Candid inks three T cell engager deals; PepGen trial put on hold

Plus, news about Foghorn Therapeutics, Incyte, BioNTech, Galderma, Basilea, Innovia, Pharming, bit.bio, Promise Bio, Outlook Therapeutics and Trevi Therapeutics: Candid Therapeutics’ trio of T cell

December 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.